Overactive Bladder - Results from #460

Outcomes of a complementary and alternative medicine based on vitamins, herbal products, and amino acid as a first line treatment in idiopathic overactive bladder syndrome in men and women without bladder outlet obstruction. February 20, 2022

Botulinum toxin for treating overactive bladder in men: A systematic review. February 20, 2022

Overactive bladder medication prescription trends from 2014 to 2018. February 13, 2022

Current advances in neuromodulation techniques in urology practices: A review of literature. February 13, 2022

The Association Between Urinary Tract Infection and Overactive Bladder Treatment. February 13, 2022

The effectiveness of different electrical nerve stimulation protocols for treating adults with non-neurogenic overactive bladder: a systematic review and meta-analysis. February 6, 2022

Comparison of Sensation Event Descriptors in Participants with Overactive and Normal Bladders during Non-Invasive Hydration Studies. February 6, 2022

Urinary incontinence, overactive bladder, and quality of life in women submitted to total hip replacement. February 6, 2022

Effectiveness of a Practical, At-Home Regimen of Parasacral Transcutaneous Electrical Nerve Stimulation in Pediatric Overactive Bladder. January 30, 2022

Sacral neuromodulation for the treatment of overactive bladder: systematic review and future prospects. January 30, 2022

A non-interventional cross-sectional re-contact study investigating the relationship between overactive bladder and frailty in older adults in Japan. January 30, 2022

Outcome reporting in randomized controlled trials (RCTs) on the pharmacological management of idiopathic overactive bladder (OAB) in women; a systematic review for the development of core outcome sets (COS). January 23, 2022

Learning Curve of Botulinum Toxin Bladder Injection for the Treatment of Refractory Overactive Bladder. January 17, 2022

Incomplete bladder emptying and urinary tract infections after botulinum toxin injection for overactive bladder: Multi-institutional collaboration from the SUFU research network. January 16, 2022

Impact of intravesical onabotulinumtoxinA (Botox) on sexual function in patients with overactive bladder syndrome: a systematic review and meta-analysis. January 16, 2022

Patient-tailored healthcare and tibial nerve neuromodulation in the treatment of patients with overactive bladder symptoms. January 16, 2022

The placebo and nocebo effects in functional urology. January 9, 2022

Physiotherapeutic assessment and management of overactive bladder syndrome: a case report. January 9, 2022

Treatment of refractory overactive bladder with OnabotulinumtoxinA vs PTNS: TROOP trial. January 9, 2022

Axonics Sacral Neuromodulation System for Treating Refractory Overactive Bladder: A NICE Medical Technologies Guidance. January 2, 2022

Page 24 of 122